Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-21 11:57 am Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Orin Hirschman | 2,717,827 6.100% |
2,717,827 (New Position) |
Filing History |
| 2024-11-14 6:25 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
ORBIMED ADVISORS LLC | 4,148,862 9.900% |
2,619,747 (+171.32%) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Nantahala Capital Management LLC | 4,052,204 9.990% |
4,052,204 (New Position) |
Filing History |
| 2024-11-14 4:38 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 4,279,521 9.990% |
1,662,119 (+63.50%) |
Filing History |
| 2024-11-14 4:36 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Alyeska Investment Group L.P. | 2,859,954 7.110% |
2,859,954 (New Position) |
Filing History |
| 2024-11-14 4:30 pm Sale |
2024-09-30 | 13G | Verastem, Inc. VSTM |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-2,531,829 (Position Closed) |
Filing History |
| 2024-11-14 3:33 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Soleus Private Equity Fund III, L.P. | 3,994,629 8.700% |
3,994,629 (New Position) |
Filing History |
| 2024-11-14 09:02 am Sale |
2024-09-30 | 13G | Verastem, Inc. VSTM |
James E. Flynn | 0 0.000% |
-1,538,461 (Position Closed) |
Filing History |
| 2024-11-13 5:39 pm Sale |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Stonepine Capital Management LLC | 2,643,620 6.400% |
-23,046 (-0.86%) |
Filing History |
| 2024-11-12 09:35 am Unchanged |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Adage Capital Management, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Verastem, Inc. VSTM |
BlackRock Inc. BLK |
2,234,699 5.600% |
0 (Unchanged) |
Filing History |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
BlackRock Inc. BLK |
2,234,699 5.600% |
2,234,699 (New Position) |
Filing History |
| 2024-07-29 4:04 pm Purchase |
2024-07-24 | 13G | Verastem, Inc. VSTM |
Stonepine Capital Management LLC | 2,666,666 6.700% |
2,666,666 (New Position) |
Filing History |
| 2024-02-14 7:31 pm Purchase |
2023-12-31 | 13G | Verastem, Inc. VSTM |
ORBIMED ADVISORS LLC | 1,529,115 6.100% |
1,529,115 (New Position) |
Filing History |
| 2024-02-14 10:00 am Purchase |
2023-12-31 | 13G | Verastem, Inc. VSTM |
VIKING GLOBAL INVESTORS LP | 2,531,829 9.990% |
1,211,173 (+91.71%) |
Filing History |
| 2024-02-14 09:20 am Purchase |
2023-12-31 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 2,617,402 9.990% |
2,617,402 (New Position) |
Filing History |
| 2024-02-13 5:01 pm Purchase |
2023-12-31 | 13G | Verastem, Inc. VSTM |
Vivo Opportunity LLC | 1,538,461 6.100% |
1,538,461 (New Position) |
Filing History |
| 2024-02-02 09:49 am Purchase |
2023-12-31 | 13G | Verastem, Inc. VSTM |
SOLEUS CAPITAL MASTER FUND, L.P. | 1,425,634 6.800% |
128,265 (+9.89%) |
Filing History |
| 2023-08-31 5:28 pm Purchase |
2023-08-21 | 13G | Verastem, Inc. VSTM |
ADAGE CAPITAL PARTNERS GP L.L.C. | 1,300,000 5.150% |
1,300,000 (New Position) |
Filing History |
| 2023-08-10 4:39 pm Sale |
2023-07-31 | 13G | Verastem, Inc. VSTM |
Baker Bros. Advisors LP | 0 0.000% |
-1,345,192 (Position Closed) |
Filing History |